SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-16-015173
Filing Date
2016-03-23
Accepted
2016-03-23 14:20:10
Documents
101
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K navb-10k_20151231.htm 10-K 5394437
2 EX-21.1 navb-ex211_8.htm EX-21.1 7664
3 EX-23.1 navb-ex231_9.htm EX-23.1 3184
4 EX-24.1 navb-ex241_10.htm EX-24.1 27647
5 EX-31.1 navb-ex311_15.htm EX-31.1 9629
6 EX-31.2 navb-ex312_16.htm EX-31.2 9672
7 EX-32.1 navb-ex321_13.htm EX-32.1 5362
8 EX-32.2 navb-ex322_14.htm EX-32.2 5300
9 GRAPHIC g3wjjliflfox000001.jpg GRAPHIC 23913
  Complete submission text file 0001564590-16-015173.txt   14891268

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT navb-20151231.xml EX-101.INS 2694610
11 XBRL TAXONOMY EXTENSION SCHEMA navb-20151231.xsd EX-101.SCH 100207
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE navb-20151231_cal.xml EX-101.CAL 75613
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE navb-20151231_def.xml EX-101.DEF 348699
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE navb-20151231_lab.xml EX-101.LAB 739303
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE navb-20151231_pre.xml EX-101.PRE 581104
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35076 | Film No.: 161523606
SIC: 2835 In Vitro & In Vivo Diagnostic Substances